Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

September 01, 1994; Volume 46,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Akeson, M

    1. You have access
      Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
      R V Benya, M Akeson, J Mrozinski, R T Jensen and J F Battey
      Molecular Pharmacology September 1994, 46 (3) 495-501;
  2. Alifimoff, J K

    1. You have access
      Does general anesthetic-induced desensitization of the Torpedo acetylcholine receptor correlate with lipid disordering?
      L L Firestone, J K Alifimoff and K W Miller
      Molecular Pharmacology September 1994, 46 (3) 508-515;
  3. Amara, S G

    1. You have access
      Stable expression of a neuronal gamma-aminobutyric acid transporter, GAT-3, in mammalian cells demonstrates unique pharmacological properties and ion dependence.
      J A Clark and S G Amara
      Molecular Pharmacology September 1994, 46 (3) 550-557;
  4. Anand, R

    1. You have access
      Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.
      X Peng, V Gerzanich, R Anand, P J Whiting and J Lindstrom
      Molecular Pharmacology September 1994, 46 (3) 523-530;

B

  1. Bard, J A

    1. You have access
      The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype.
      T M Laz, C Forray, K E Smith, J A Bard, P J Vaysse, T A Branchek and R L Weinshank
      Molecular Pharmacology September 1994, 46 (3) 414-422;
  2. Barret, J M

    1. You have access
      A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity.
      J M Barret, P Calsou, A K Larsen and B Salles
      Molecular Pharmacology September 1994, 46 (3) 431-436;
  3. Battey, J F

    1. You have access
      Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
      R V Benya, M Akeson, J Mrozinski, R T Jensen and J F Battey
      Molecular Pharmacology September 1994, 46 (3) 495-501;
  4. Beavo, J A

    1. You have access
      Multiple cyclic nucleotide phosphodiesterases.
      J A Beavo, M Conti and R J Heaslip
      Molecular Pharmacology September 1994, 46 (3) 399-405;
  5. Benya, R V

    1. You have access
      Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
      R V Benya, M Akeson, J Mrozinski, R T Jensen and J F Battey
      Molecular Pharmacology September 1994, 46 (3) 495-501;
  6. Berg, K A

    1. You have access
      Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
      K A Berg, W P Clarke, C Sailstad, A Saltzman and S Maayani
      Molecular Pharmacology September 1994, 46 (3) 477-484;
  7. Bertilsson, L

    1. You have access
      Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.
      I Johansson, M Oscarson, Q Y Yue, L Bertilsson, F Sjöqvist and M Ingelman-Sundberg
      Molecular Pharmacology September 1994, 46 (3) 452-459;
  8. Birnbaumer, L

    1. You have access
      Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density.
      X Zhu, S Gilbert, M Birnbaumer and L Birnbaumer
      Molecular Pharmacology September 1994, 46 (3) 460-469;
  9. Birnbaumer, M

    1. You have access
      Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density.
      X Zhu, S Gilbert, M Birnbaumer and L Birnbaumer
      Molecular Pharmacology September 1994, 46 (3) 460-469;
  10. Bonanno, G

    1. You have access
      Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes.
      A Gemignani, P Paudice, G Bonanno and M Raiteri
      Molecular Pharmacology September 1994, 46 (3) 558-562;
  11. Boring, D

    1. You have access
      Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;
  12. Bouchard, B

    1. You have access
      Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
      R Le Panse, B Coulomb, V Mitev, B Bouchard, C Lebreton and L Dubertret
      Molecular Pharmacology September 1994, 46 (3) 445-451;
  13. Branchek, T A

    1. You have access
      The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype.
      T M Laz, C Forray, K E Smith, J A Bard, P J Vaysse, T A Branchek and R L Weinshank
      Molecular Pharmacology September 1994, 46 (3) 414-422;
  14. Brown, J H

    1. You have access
      Rapid heterologous desensitization of muscarinic and thrombin receptor-mediated phospholipase D activation.
      M Nieto, E Kennedy, D Goldstein and J H Brown
      Molecular Pharmacology September 1994, 46 (3) 406-413;

C

  1. Calsou, P

    1. You have access
      A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity.
      J M Barret, P Calsou, A K Larsen and B Salles
      Molecular Pharmacology September 1994, 46 (3) 431-436;
  2. Cantrell, C H

    1. You have access
      Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;
  3. Clark, J A

    1. You have access
      Stable expression of a neuronal gamma-aminobutyric acid transporter, GAT-3, in mammalian cells demonstrates unique pharmacological properties and ion dependence.
      J A Clark and S G Amara
      Molecular Pharmacology September 1994, 46 (3) 550-557;
  4. Clarke, W P

    1. You have access
      Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
      K A Berg, W P Clarke, C Sailstad, A Saltzman and S Maayani
      Molecular Pharmacology September 1994, 46 (3) 477-484;
  5. Conti, M

    1. You have access
      Multiple cyclic nucleotide phosphodiesterases.
      J A Beavo, M Conti and R J Heaslip
      Molecular Pharmacology September 1994, 46 (3) 399-405;
  6. Cook, J M

    1. You have access
      Epoxide metabolite of quinine and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
      P W Wigler, K L Lyon, F K Patterson, A J La Loggia, H Diaz-Araúzo, M S Reddy and J M Cook
      Molecular Pharmacology September 1994, 46 (3) 562-567;
  7. Coulomb, B

    1. You have access
      Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
      R Le Panse, B Coulomb, V Mitev, B Bouchard, C Lebreton and L Dubertret
      Molecular Pharmacology September 1994, 46 (3) 445-451;

D

  1. Dettbarn, C

    1. You have access
      Many agonists induce "quantal" Ca2+ release or adaptive behavior in muscle ryanodine receptors.
      C Dettbarn, S Györke and P Palade
      Molecular Pharmacology September 1994, 46 (3) 502-507;
  2. Diaz-Araúzo, H

    1. You have access
      Epoxide metabolite of quinine and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
      P W Wigler, K L Lyon, F K Patterson, A J La Loggia, H Diaz-Araúzo, M S Reddy and J M Cook
      Molecular Pharmacology September 1994, 46 (3) 562-567;
  3. Dorai, T

    1. You have access
      Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
      T Dorai, H Kobayashi, J F Holland and T Ohnuma
      Molecular Pharmacology September 1994, 46 (3) 437-444;
  4. Dubertret, L

    1. You have access
      Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
      R Le Panse, B Coulomb, V Mitev, B Bouchard, C Lebreton and L Dubertret
      Molecular Pharmacology September 1994, 46 (3) 445-451;

E

  1. Evans, D M

    1. You have access
      Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;

F

  1. Farb, D H

    1. You have access
      Phosphorylation factors control neurotransmitter and neuromodulator actions at the gamma-aminobutyric acid type A receptor.
      M Gyenes, Q Wang, T T Gibbs and D H Farb
      Molecular Pharmacology September 1994, 46 (3) 542-549;
  2. Firestone, L L

    1. You have access
      Does general anesthetic-induced desensitization of the Torpedo acetylcholine receptor correlate with lipid disordering?
      L L Firestone, J K Alifimoff and K W Miller
      Molecular Pharmacology September 1994, 46 (3) 508-515;
  3. Forray, C

    1. You have access
      The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype.
      T M Laz, C Forray, K E Smith, J A Bard, P J Vaysse, T A Branchek and R L Weinshank
      Molecular Pharmacology September 1994, 46 (3) 414-422;

G

  1. Ge, J L

    1. You have access
      Specificity and directionality of thiol effects on sinusoidal glutathione transport in rat liver.
      S C Lu, J Kuhlenkamp, J L Ge, W M Sun and N Kaplowitz
      Molecular Pharmacology September 1994, 46 (3) 578-585;
  2. Gemignani, A

    1. You have access
      Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes.
      A Gemignani, P Paudice, G Bonanno and M Raiteri
      Molecular Pharmacology September 1994, 46 (3) 558-562;
  3. Gerzanich, V

    1. You have access
      Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.
      X Peng, V Gerzanich, R Anand, P J Whiting and J Lindstrom
      Molecular Pharmacology September 1994, 46 (3) 523-530;
  4. Gibbs, T T

    1. You have access
      Phosphorylation factors control neurotransmitter and neuromodulator actions at the gamma-aminobutyric acid type A receptor.
      M Gyenes, Q Wang, T T Gibbs and D H Farb
      Molecular Pharmacology September 1994, 46 (3) 542-549;
  5. Gilbert, S

    1. You have access
      Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density.
      X Zhu, S Gilbert, M Birnbaumer and L Birnbaumer
      Molecular Pharmacology September 1994, 46 (3) 460-469;
  6. Goldstein, D

    1. You have access
      Rapid heterologous desensitization of muscarinic and thrombin receptor-mediated phospholipase D activation.
      M Nieto, E Kennedy, D Goldstein and J H Brown
      Molecular Pharmacology September 1994, 46 (3) 406-413;
  7. Guengerich, F P

    1. You have access
      Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
      H Yamazaki, Z Guo, M Persmark, M Mimura, K Inoue, F P Guengerich and T Shimada
      Molecular Pharmacology September 1994, 46 (3) 568-577;
  8. Guo, Z

    1. You have access
      Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
      H Yamazaki, Z Guo, M Persmark, M Mimura, K Inoue, F P Guengerich and T Shimada
      Molecular Pharmacology September 1994, 46 (3) 568-577;
  9. Gyenes, M

    1. You have access
      Phosphorylation factors control neurotransmitter and neuromodulator actions at the gamma-aminobutyric acid type A receptor.
      M Gyenes, Q Wang, T T Gibbs and D H Farb
      Molecular Pharmacology September 1994, 46 (3) 542-549;
  10. Györke, S

    1. You have access
      Many agonists induce "quantal" Ca2+ release or adaptive behavior in muscle ryanodine receptors.
      C Dettbarn, S Györke and P Palade
      Molecular Pharmacology September 1994, 46 (3) 502-507;

H

  1. Harbon, S

    1. You have access
      Endothelin receptor type A signals both the accumulation of inositol phosphates and the inhibition of cyclic AMP generation in rat myometrium: stimulation and desensitization.
      L D Khac, S Naze and S Harbon
      Molecular Pharmacology September 1994, 46 (3) 485-494;
  2. Heaslip, R J

    1. You have access
      Multiple cyclic nucleotide phosphodiesterases.
      J A Beavo, M Conti and R J Heaslip
      Molecular Pharmacology September 1994, 46 (3) 399-405;
  3. Holland, J F

    1. You have access
      Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
      T Dorai, H Kobayashi, J F Holland and T Ohnuma
      Molecular Pharmacology September 1994, 46 (3) 437-444;
  4. Howlett, A C

    1. You have access
      Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;

I

  1. Ingelman-Sundberg, M

    1. You have access
      Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.
      I Johansson, M Oscarson, Q Y Yue, L Bertilsson, F Sjöqvist and M Ingelman-Sundberg
      Molecular Pharmacology September 1994, 46 (3) 452-459;
  2. Inoue, K

    1. You have access
      Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
      H Yamazaki, Z Guo, M Persmark, M Mimura, K Inoue, F P Guengerich and T Shimada
      Molecular Pharmacology September 1994, 46 (3) 568-577;
  3. Izumi, F

    1. You have access
      Occurrence and activation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in bovine adrenal medullary cells.
      N Yanagihara, Y Toyohira, H Yamamoto, Y Ohta, M Tsutsui, E Miyamoto and F Izumi
      Molecular Pharmacology September 1994, 46 (3) 423-430;

J

  1. Jensen, R T

    1. You have access
      Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
      R V Benya, M Akeson, J Mrozinski, R T Jensen and J F Battey
      Molecular Pharmacology September 1994, 46 (3) 495-501;
  2. Johansson, I

    1. You have access
      Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.
      I Johansson, M Oscarson, Q Y Yue, L Bertilsson, F Sjöqvist and M Ingelman-Sundberg
      Molecular Pharmacology September 1994, 46 (3) 452-459;
  3. Johnson, M R

    1. You have access
      Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;

K

  1. Kaplowitz, N

    1. You have access
      Specificity and directionality of thiol effects on sinusoidal glutathione transport in rat liver.
      S C Lu, J Kuhlenkamp, J L Ge, W M Sun and N Kaplowitz
      Molecular Pharmacology September 1994, 46 (3) 578-585;
  2. Kennedy, E

    1. You have access
      Rapid heterologous desensitization of muscarinic and thrombin receptor-mediated phospholipase D activation.
      M Nieto, E Kennedy, D Goldstein and J H Brown
      Molecular Pharmacology September 1994, 46 (3) 406-413;
  3. Khac, L D

    1. You have access
      Endothelin receptor type A signals both the accumulation of inositol phosphates and the inhibition of cyclic AMP generation in rat myometrium: stimulation and desensitization.
      L D Khac, S Naze and S Harbon
      Molecular Pharmacology September 1994, 46 (3) 485-494;
  4. Kobayashi, H

    1. You have access
      Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
      T Dorai, H Kobayashi, J F Holland and T Ohnuma
      Molecular Pharmacology September 1994, 46 (3) 437-444;
  5. Kuhlenkamp, J

    1. You have access
      Specificity and directionality of thiol effects on sinusoidal glutathione transport in rat liver.
      S C Lu, J Kuhlenkamp, J L Ge, W M Sun and N Kaplowitz
      Molecular Pharmacology September 1994, 46 (3) 578-585;

L

  1. La Loggia, A J

    1. You have access
      Epoxide metabolite of quinine and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
      P W Wigler, K L Lyon, F K Patterson, A J La Loggia, H Diaz-Araúzo, M S Reddy and J M Cook
      Molecular Pharmacology September 1994, 46 (3) 562-567;
  2. Larsen, A K

    1. You have access
      A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity.
      J M Barret, P Calsou, A K Larsen and B Salles
      Molecular Pharmacology September 1994, 46 (3) 431-436;
  3. Laz, T M

    1. You have access
      The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype.
      T M Laz, C Forray, K E Smith, J A Bard, P J Vaysse, T A Branchek and R L Weinshank
      Molecular Pharmacology September 1994, 46 (3) 414-422;
  4. Lebreton, C

    1. You have access
      Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
      R Le Panse, B Coulomb, V Mitev, B Bouchard, C Lebreton and L Dubertret
      Molecular Pharmacology September 1994, 46 (3) 445-451;
  5. Le Panse, R

    1. You have access
      Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
      R Le Panse, B Coulomb, V Mitev, B Bouchard, C Lebreton and L Dubertret
      Molecular Pharmacology September 1994, 46 (3) 445-451;
  6. Lindstrom, J

    1. You have access
      Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.
      X Peng, V Gerzanich, R Anand, P J Whiting and J Lindstrom
      Molecular Pharmacology September 1994, 46 (3) 523-530;
  7. Lu, S C

    1. You have access
      Specificity and directionality of thiol effects on sinusoidal glutathione transport in rat liver.
      S C Lu, J Kuhlenkamp, J L Ge, W M Sun and N Kaplowitz
      Molecular Pharmacology September 1994, 46 (3) 578-585;
  8. Lyon, K L

    1. You have access
      Epoxide metabolite of quinine and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
      P W Wigler, K L Lyon, F K Patterson, A J La Loggia, H Diaz-Araúzo, M S Reddy and J M Cook
      Molecular Pharmacology September 1994, 46 (3) 562-567;

M

  1. Maayani, S

    1. You have access
      Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
      K A Berg, W P Clarke, C Sailstad, A Saltzman and S Maayani
      Molecular Pharmacology September 1994, 46 (3) 477-484;
  2. Miller, K W

    1. You have access
      Does general anesthetic-induced desensitization of the Torpedo acetylcholine receptor correlate with lipid disordering?
      L L Firestone, J K Alifimoff and K W Miller
      Molecular Pharmacology September 1994, 46 (3) 508-515;
  3. Mimura, M

    1. You have access
      Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
      H Yamazaki, Z Guo, M Persmark, M Mimura, K Inoue, F P Guengerich and T Shimada
      Molecular Pharmacology September 1994, 46 (3) 568-577;
  4. Mitev, V

    1. You have access
      Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X.
      R Le Panse, B Coulomb, V Mitev, B Bouchard, C Lebreton and L Dubertret
      Molecular Pharmacology September 1994, 46 (3) 445-451;
  5. Miyamoto, E

    1. You have access
      Occurrence and activation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in bovine adrenal medullary cells.
      N Yanagihara, Y Toyohira, H Yamamoto, Y Ohta, M Tsutsui, E Miyamoto and F Izumi
      Molecular Pharmacology September 1994, 46 (3) 423-430;
  6. Mrozinski, J

    1. You have access
      Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
      R V Benya, M Akeson, J Mrozinski, R T Jensen and J F Battey
      Molecular Pharmacology September 1994, 46 (3) 495-501;

N

  1. Naze, S

    1. You have access
      Endothelin receptor type A signals both the accumulation of inositol phosphates and the inhibition of cyclic AMP generation in rat myometrium: stimulation and desensitization.
      L D Khac, S Naze and S Harbon
      Molecular Pharmacology September 1994, 46 (3) 485-494;
  2. Nieto, M

    1. You have access
      Rapid heterologous desensitization of muscarinic and thrombin receptor-mediated phospholipase D activation.
      M Nieto, E Kennedy, D Goldstein and J H Brown
      Molecular Pharmacology September 1994, 46 (3) 406-413;

O

  1. Ohnuma, T

    1. You have access
      Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
      T Dorai, H Kobayashi, J F Holland and T Ohnuma
      Molecular Pharmacology September 1994, 46 (3) 437-444;
  2. Ohta, Y

    1. You have access
      Occurrence and activation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in bovine adrenal medullary cells.
      N Yanagihara, Y Toyohira, H Yamamoto, Y Ohta, M Tsutsui, E Miyamoto and F Izumi
      Molecular Pharmacology September 1994, 46 (3) 423-430;
  3. Oscarson, M

    1. You have access
      Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.
      I Johansson, M Oscarson, Q Y Yue, L Bertilsson, F Sjöqvist and M Ingelman-Sundberg
      Molecular Pharmacology September 1994, 46 (3) 452-459;

P

  1. Palade, P

    1. You have access
      Many agonists induce "quantal" Ca2+ release or adaptive behavior in muscle ryanodine receptors.
      C Dettbarn, S Györke and P Palade
      Molecular Pharmacology September 1994, 46 (3) 502-507;
  2. Patterson, F K

    1. You have access
      Epoxide metabolite of quinine and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
      P W Wigler, K L Lyon, F K Patterson, A J La Loggia, H Diaz-Araúzo, M S Reddy and J M Cook
      Molecular Pharmacology September 1994, 46 (3) 562-567;
  3. Paudice, P

    1. You have access
      Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes.
      A Gemignani, P Paudice, G Bonanno and M Raiteri
      Molecular Pharmacology September 1994, 46 (3) 558-562;
  4. Peng, X

    1. You have access
      Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.
      X Peng, V Gerzanich, R Anand, P J Whiting and J Lindstrom
      Molecular Pharmacology September 1994, 46 (3) 523-530;
  5. Persmark, M

    1. You have access
      Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
      H Yamazaki, Z Guo, M Persmark, M Mimura, K Inoue, F P Guengerich and T Shimada
      Molecular Pharmacology September 1994, 46 (3) 568-577;
  6. Pinto, J C

    1. You have access
      Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;
  7. Potié, F

    1. You have access
      Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;

R

  1. Raiteri, M

    1. You have access
      Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes.
      A Gemignani, P Paudice, G Bonanno and M Raiteri
      Molecular Pharmacology September 1994, 46 (3) 558-562;
  2. Reddy, M S

    1. You have access
      Epoxide metabolite of quinine and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
      P W Wigler, K L Lyon, F K Patterson, A J La Loggia, H Diaz-Araúzo, M S Reddy and J M Cook
      Molecular Pharmacology September 1994, 46 (3) 562-567;
  3. Rice, K C

    1. You have access
      Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;
  4. Richelson, E

    1. You have access
      Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells.
      M Yamada, M Yamada, M A Watson and E Richelson
      Molecular Pharmacology September 1994, 46 (3) 470-476;

S

  1. Sailstad, C

    1. You have access
      Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
      K A Berg, W P Clarke, C Sailstad, A Saltzman and S Maayani
      Molecular Pharmacology September 1994, 46 (3) 477-484;
  2. Salles, B

    1. You have access
      A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity.
      J M Barret, P Calsou, A K Larsen and B Salles
      Molecular Pharmacology September 1994, 46 (3) 431-436;
  3. Saltzman, A

    1. You have access
      Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
      K A Berg, W P Clarke, C Sailstad, A Saltzman and S Maayani
      Molecular Pharmacology September 1994, 46 (3) 477-484;
  4. Shimada, T

    1. You have access
      Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
      H Yamazaki, Z Guo, M Persmark, M Mimura, K Inoue, F P Guengerich and T Shimada
      Molecular Pharmacology September 1994, 46 (3) 568-577;
  5. Sjöqvist, F

    1. You have access
      Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.
      I Johansson, M Oscarson, Q Y Yue, L Bertilsson, F Sjöqvist and M Ingelman-Sundberg
      Molecular Pharmacology September 1994, 46 (3) 452-459;
  6. Smith, K E

    1. You have access
      The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype.
      T M Laz, C Forray, K E Smith, J A Bard, P J Vaysse, T A Branchek and R L Weinshank
      Molecular Pharmacology September 1994, 46 (3) 414-422;
  7. Sun, W M

    1. You have access
      Specificity and directionality of thiol effects on sinusoidal glutathione transport in rat liver.
      S C Lu, J Kuhlenkamp, J L Ge, W M Sun and N Kaplowitz
      Molecular Pharmacology September 1994, 46 (3) 578-585;

T

  1. Toyohira, Y

    1. You have access
      Occurrence and activation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in bovine adrenal medullary cells.
      N Yanagihara, Y Toyohira, H Yamamoto, Y Ohta, M Tsutsui, E Miyamoto and F Izumi
      Molecular Pharmacology September 1994, 46 (3) 423-430;
  2. Tsutsui, M

    1. You have access
      Occurrence and activation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in bovine adrenal medullary cells.
      N Yanagihara, Y Toyohira, H Yamamoto, Y Ohta, M Tsutsui, E Miyamoto and F Izumi
      Molecular Pharmacology September 1994, 46 (3) 423-430;

V

  1. Vaysse, P J

    1. You have access
      The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype.
      T M Laz, C Forray, K E Smith, J A Bard, P J Vaysse, T A Branchek and R L Weinshank
      Molecular Pharmacology September 1994, 46 (3) 414-422;

W

  1. Wang, Q

    1. You have access
      Phosphorylation factors control neurotransmitter and neuromodulator actions at the gamma-aminobutyric acid type A receptor.
      M Gyenes, Q Wang, T T Gibbs and D H Farb
      Molecular Pharmacology September 1994, 46 (3) 542-549;
  2. Watson, M A

    1. You have access
      Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells.
      M Yamada, M Yamada, M A Watson and E Richelson
      Molecular Pharmacology September 1994, 46 (3) 470-476;
  3. Weinshank, R L

    1. You have access
      The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype.
      T M Laz, C Forray, K E Smith, J A Bard, P J Vaysse, T A Branchek and R L Weinshank
      Molecular Pharmacology September 1994, 46 (3) 414-422;
  4. Whiting, P J

    1. You have access
      Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.
      X Peng, V Gerzanich, R Anand, P J Whiting and J Lindstrom
      Molecular Pharmacology September 1994, 46 (3) 523-530;
  5. Wigler, P W

    1. You have access
      Epoxide metabolite of quinine and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
      P W Wigler, K L Lyon, F K Patterson, A J La Loggia, H Diaz-Araúzo, M S Reddy and J M Cook
      Molecular Pharmacology September 1994, 46 (3) 562-567;
  6. Wilken, G H

    1. You have access
      Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
      J C Pinto, F Potié, K C Rice, D Boring, M R Johnson, D M Evans, G H Wilken, C H Cantrell and A C Howlett
      Molecular Pharmacology September 1994, 46 (3) 516-522;
  7. Williams, K

    1. You have access
      Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine.
      K Williams
      Molecular Pharmacology September 1994, 46 (3) 531-541;

Y

  1. Yamada, M

    1. You have access
      Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells.
      M Yamada, M Yamada, M A Watson and E Richelson
      Molecular Pharmacology September 1994, 46 (3) 470-476;
    2. You have access
      Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells.
      M Yamada, M Yamada, M A Watson and E Richelson
      Molecular Pharmacology September 1994, 46 (3) 470-476;
  2. Yamamoto, H

    1. You have access
      Occurrence and activation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in bovine adrenal medullary cells.
      N Yanagihara, Y Toyohira, H Yamamoto, Y Ohta, M Tsutsui, E Miyamoto and F Izumi
      Molecular Pharmacology September 1994, 46 (3) 423-430;
  3. Yamazaki, H

    1. You have access
      Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
      H Yamazaki, Z Guo, M Persmark, M Mimura, K Inoue, F P Guengerich and T Shimada
      Molecular Pharmacology September 1994, 46 (3) 568-577;
  4. Yanagihara, N

    1. You have access
      Occurrence and activation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in bovine adrenal medullary cells.
      N Yanagihara, Y Toyohira, H Yamamoto, Y Ohta, M Tsutsui, E Miyamoto and F Izumi
      Molecular Pharmacology September 1994, 46 (3) 423-430;
  5. Yue, Q Y

    1. You have access
      Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.
      I Johansson, M Oscarson, Q Y Yue, L Bertilsson, F Sjöqvist and M Ingelman-Sundberg
      Molecular Pharmacology September 1994, 46 (3) 452-459;

Z

  1. Zhu, X

    1. You have access
      Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density.
      X Zhu, S Gilbert, M Birnbaumer and L Birnbaumer
      Molecular Pharmacology September 1994, 46 (3) 460-469;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 46, Issue 3
1 Sep 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Proteomic Analysis of GPCR Cell Biology
  • Phosphoproteomic Analysis of cAMP-Dependent Pathways
  • Phosphoproteomic Identification of Signaling Pathways
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Characterization of GRD and LCCH3 from Human Louse
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics